The Nuclear Medicine Division of the Department of Radiology provides a two-year ACGME accredited residency in Nuclear Medicine. The residency experience provides a broad understanding of advanced techniques in Nuclear Oncology, Nuclear Cardiology and in molecular imaging. Candidates must meet the preliminary requirements defined by the American Board of Nuclear Medicine.
The close association with the Department of Radiation Oncology and the Greenebaum Cancer Center enhances the program experience in Nuclear Oncology. The integrated University/VA Nuclear Medicine program has advanced attenuation correcting SPECT cameras, as well as dedicated PET and coincidence PET-CT imaging devices. The residency includes training in therapy using I-131 radioiodine, Sr89, Sm153, as well as Y90 microspheres, Y90 monoclonal antibodies and Re188 peptides. There is ample opportunity to participate in FDA approved therapeutic protocols and clinical trials.
The faculty of the Division of Nuclear Medicine hold multiple NIH and DOD funded grants related to developing diagnostic and therapeutic radiobiologics. These grants are supported by a 4500 sq ft laboratory and animal-imaging complex dedicated to radiopharmaceutical research. PET/CT, alpha emitter, and cyclotron based radiopharmaceutical programs are being developed.
The residency program provides an outstanding experience in Nuclear Cardiology. Several faculty are boarded in both Cardiology and Nuclear Medicine and hold dual appointments in Nuclear Medicine and Cardiology.
The clinical facilities house two cardiac stress labs, multiple dual head attenuation correcting SPECT cameras and specially trained stress technicians. The program provides a broad exposure to all pharmacologic and stress protocols, imaging agents and cardiac PET studies. There is active participation in multicenter trials of myocardial perfusion and cardiac receptor imaging agents.
A variable number of Fellows in various subspecialties (Nuclear Radiology, Cardiology) are in training in the division of nuclear medicine. Care is taken to be certain that Fellows do not supplant residents for faculty time or case material.
All residents must complete a clinical internship as required by the American Board of Nuclear Medicine. Two years of residency training are then required. Annual appointments beginning each July 1st are renewable yearly upon satisfactory performance and progress during the previous year.
The total working hours for residency, resident call, and authorized moonlighting is not allowed to exceed 80 working hours per week. Unauthorized moonlighting is prohibited.
|
Email this Page
Print this Page © 2008 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System, 22 S. Greene
Street, Baltimore, MD 21201. 1.800.492.5538 TDD: 1.800.735.2258
Physician Referral: 1.800.373.4111
